DalsnaFinance › IPOs › Adc Therapeutics SA › IPO
ADC Therapeutics SA completed its initial public offering on NYSE on May 15, 2020, pricing at $19.00 a share.
| Ticker | ADCT |
|---|---|
| Exchange | NYSE |
| Status | Completed |
| Listing date | May 15, 2020 |
| Offering price | $19.00 |
| Shares offered | 12,245,631 |
| Total raised | $233M |
ADC Therapeutics SA sold 12,245,631 shares at $19.00 each on NYSE. Multiplied out, that is $232.7 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $233 million total recorded for the deal.
ADC Therapeutics SA — quote, profile and latest news →
Source: SEC EDGAR filings for ADC Therapeutics SA. This page is general information, not investment advice.